These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31404182)

  • 1. Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India.
    Agrawal V; Shrivastava TP; Adusumilli PK; Vivekanandan K; Thota P; Bhushan S
    Perspect Clin Res; 2019; 10(3):140-144. PubMed ID: 31404182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacovigilance in India: Present Scenario and Future Challenges.
    Kalaiselvan V; Srivastava S; Singh A; Gupta SK
    Drug Saf; 2019 Mar; 42(3):339-346. PubMed ID: 30269244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Resistance: Progress in the Decade since Emergence of New Delhi Metallo-β-Lactamase in India.
    Dixit A; Kumar N; Kumar S; Trigun V
    Indian J Community Med; 2019; 44(1):4-8. PubMed ID: 30983704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Pharmacovigilance System in India and Paradigm of Pharmacovigilance Research: An Overview.
    Singh P; Vaishnav Y; Verma S
    Curr Drug Saf; 2023; 18(4):448-464. PubMed ID: 36200243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefixime-associated acute generalized exanthematous pustulosis: Rare cases in India.
    Kumar V; Kalaiselvan V; Kumar AP; Saurabh A; Thota P; Sidhu S; Medhi B
    Indian J Pharmacol; 2018; 50(4):204-207. PubMed ID: 30505057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in pharmacovigilance initiatives surrounding antimicrobial resistance-Indian perspective.
    Bairy LK; Nayak V; A A; Kunder SK
    Expert Opin Drug Saf; 2016 Aug; 15(8):1055-62. PubMed ID: 27142491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic monoclonal antibodies and the need for targeted pharmacovigilance in India.
    Kalaivani M; Singh A; Kalaiselvan V
    MAbs; 2015; 7(1):276-80. PubMed ID: 25523367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India.
    Kumar P; Kaur I; Kalaiselvan V; Singh A
    Indian J Anaesth; 2017 Jul; 61(7):534-537. PubMed ID: 28794523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Resistance in Nepal.
    Acharya KP; Wilson RT
    Front Med (Lausanne); 2019; 6():105. PubMed ID: 31179281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance in the environment: The Indian scenario.
    Taneja N; Sharma M
    Indian J Med Res; 2019 Feb; 149(2):119-128. PubMed ID: 31219076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Easy Access to Antibiotics; Spread of Antimicrobial Resistance and Implementation of One Health Approach in India.
    Jani K; Srivastava V; Sharma P; Vir A; Sharma A
    J Epidemiol Glob Health; 2021 Dec; 11(4):444-452. PubMed ID: 34734384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new Korean action plan for containment of antimicrobial resistance.
    Ryu S
    J Glob Antimicrob Resist; 2017 Mar; 8():70-73. PubMed ID: 28024981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India.
    Thota P; Thota A; Medhi B; Sidhu S; Kumar P; Selvan VK; Singh GN
    Perspect Clin Res; 2018; 9(1):51-55. PubMed ID: 29430420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population knowledge and awareness of antibiotic use and antimicrobial resistance: results from national household survey 2019 and changes from 2017.
    Tangcharoensathien V; Chanvatik S; Kosiyaporn H; Kirivan S; Kaewkhankhaeng W; Thunyahan A; Lekagul A
    BMC Public Health; 2021 Nov; 21(1):2188. PubMed ID: 34844593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Challenge of Antimicrobial Resistance in the Indian Healthcare System.
    Sharma A; Thakur N; Thakur A; Chauhan A; Babrah H
    Cureus; 2023 Jul; 15(7):e42231. PubMed ID: 37605711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tackling antibiotic resistance in India.
    Wattal C; Goel N
    Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1427-40. PubMed ID: 25353717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appraising Nigeria's approach to combating antimicrobial resistance.
    Onah SI; Umar HJ
    Int J Health Plann Manage; 2024 Mar; 39(2):556-562. PubMed ID: 37846033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "ADR PvPI" Android mobile app: Report adverse drug reaction at any time anywhere in India.
    Prakash J; Joshi K; Malik D; Mishra O; Sachan A; Kumar B; Bhushan S; Kalaiselvan V; Singh GN
    Indian J Pharmacol; 2019; 51(4):236-242. PubMed ID: 31571709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, roll-out and implementation of an antimicrobial resistance training curriculum harmonizes delivery of in-service training to healthcare workers in Kenya.
    Njeru J; Odero J; Chebore S; Ndung'u M; Tanui E; Wesangula E; Ndanyi R; Githii S; Gunturu R; Mwangi W; Mutonga D; Dahourou A; Thaiyah A
    Front Microbiol; 2023; 14():1142622. PubMed ID: 37593544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding complexities in the uptake of indigenously developed rapid point-of-care diagnostics for containment of antimicrobial resistance in India.
    Sharma M; Gangakhedkar RR; Bhattacharya S; Walia K
    BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34580070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.